E-LIB Suche - Ergebnisse für: Luraghi, Paolo

1

MicroRNA 483‐3p overexpression unleashes invasive growth of..:

Candiello, Ermes ; Reato, Gigliola ; Verginelli, Federica...
Molecular Oncology. 17 (2023) 7 - p. 1280-1301 , 2023

Link: https://doi.org/10.1002/..

2

Temozolomide Treatment Alters Mismatch Repair and Boosts Mu..:

Crisafulli, Giovanni ; Sartore-Bianchi, Andrea ; Lazzari, Luca...
Cancer Discovery. 12 (2022) 7 - p. 1656-1675 , 2022

Link: https://doi.org/10.1158/..

3

METinhibition overcomes radiation resistance of glioblastom..:

De Bacco, Francesca ; D'Ambrosio, Antonio ; Casanova, Elena...
EMBO Molecular Medicine. 8 (2016) 5 - p. 550-568 , 2016

Link: https://doi.org/10.15252..

4

The MET Oncogene as a Therapeutical Target in Cancer Invasi..:

Luraghi, Paolo ; Schelter, Florian ; Krüger, Achim.
Frontiers in Pharmacology. 3 (2012) - p. , 2012

Link: https://doi.org/10.3389/..

5

Induction of MET by Ionizing Radiation and Its Role in Radi..:

De Bacco, Francesca ; Luraghi, Paolo ; Medico, Enzo...
JNCI: Journal of the National Cancer Institute. 103 (2011) 8 - p. 645-661 , 2011

Link: https://doi.org/10.1093/..

6

Poised Transcription Factories Prime Silent uPA Gene Prior ..:

Ferrai, Carmelo ; Xie, Sheila Q. ; Luraghi, Paolo...
PLoS Biology. 8 (2010) 1 - p. e1000270 , 2010

Link: https://doi.org/10.1371/..

7

Kinetic assay for characterization of spleen tyrosine kinas..:

Li, Min ; Luraghi, Paolo ; Amour, Augustin...
Analytical Biochemistry. 384 (2009) 1 - p. 56-67 , 2009

Link: https://doi.org/10.1016/..

8

A Transcription-dependent Micrococcal Nuclease-resistant Fr..:

Ferrai, Carmelo ; Munari, Davide ; Luraghi, Paolo...
Journal of Biological Chemistry. 282 (2007) 17 - p. 12537-12546 , 2007

Link: https://doi.org/10.1074/..

9

MicroRNA 483‐3p overexpression unleashes invasive growth of..:

Candiello, Ermes ; Reato, Gigliola ; Verginelli, Federica...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323897/. , 2023

Link: http://www.ncbi.nlm.nih...

10

Temozolomide treatment alters mismatch repair and boosts mu..:

Crisafulli, Giovanni ; Sartore-Bianchi, Andrea ; Lazzari, Luca...
info:eu-repo/semantics/altIdentifier/pmid/35522273. , 2022

Link: http://hdl.handle.net/23..

11

Temozolomide Treatment Alters Mismatch Repair and Boosts Mu..:

Crisafulli, Giovanni ; Sartore-Bianchi, Andrea ; Lazzari, Luca...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394384/. , 2022

Link: http://www.ncbi.nlm.nih...

12

Temozolomide treatment alters mismatch repair and boosts mu..:

Crisafulli, Giovanni ; Sartore-Bianchi, Andrea ; Lazzari, Luca...
info:eu-repo/semantics/altIdentifier/pmid/35522273. , 2022

Link: http://hdl.handle.net/24..

13

Colorectal cancer residual disease at maximal response to E..:

Lupo, Barbara ; Sassi, Francesco ; Pinnelli, Marika...
info:eu-repo/grantAgreement/EC/H2020/754923/. , 2020

Link: https://zenodo.org/recor..

14

Colorectal cancer residual disease at maximal response to E..:

Lupo, Barbara ; Sassi, Francesco ; Pinnelli, Marika...
info:eu-repo/semantics/altIdentifier/wos/WOS:000558819900002. , 2020

Link: http://hdl.handle.net/23..

15

A molecularly annotated model of patient-derived colon canc..:

Luraghi, Paolo ; Bigatto, Viola ; CIPRIANO, ELIA...
info:eu-repo/semantics/altIdentifier/pmid/28974546. , 2018

Link: http://hdl.handle.net/23..